Michael McCully is the founder of Syndeio Biosciences. Syndeio Biosciences has raised $90M in total funding. Latest round: Series A.
Michael G. McCully is the Co-Founder, President, and Chief Operating Officer of Syndeio Biosciences, a clinical-stage biotechnology company focused on central nervous system diseases. He leads efforts to advance therapies for restoring and enhancing synaptic health.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide